News

HSBC predicts strong performance for Reckitt Benckiser in H2 2025, citing robust growth, cost savings, and operational ...
Reckitt Benckiser announced a new share buyback program and during the next 12 months, the company will repurchase shares worth GBP 1 billion. Reckitt Benckiser Q3/23 Presentation.
Reckitt Benckiser is pulling Suboxone tablets, which lost patent protection, from the US market, claiming children can be accidentally harmed, but won't do so for a few months. Meanwhile, Reckitt ...
Reckitt Benckiser was formed in 1999 through the merger of the British firm Reckitt & Colman and Dutch-based Benckiser. Recently rebranded under the corporate name Reckitt, it sells a portfolio ...
Consumer goods giant Reckitt Benckiser RKT-0.04%decrease; red down pointing triangle isn’t exactly in limbo, even as it awaits a new chief executive. The maker of Lysol and Clearasil posted ...
British company Reckitt Benckiser has agreed to pay $1.4 billion to resolve all U.S. government investigations and claims in what is the biggest drug industry settlement to date stemming from the ...
Durex and Nurofen maker Reckitt Benckiser is facing the departure of four senior executives in the biggest management reshuffle since Rakesh Kapoor took the helm six years ago.
Reckitt Benckiser Group Plc’s heads of information technology, human resources, marketing, and developing markets will leave in the company’s biggest management changes since Rakesh Kapoor ...
Shares in British consumer goods company Reckitt Benckiser jumped over 10% on Friday after the company, along with U.S.-based Abbott Labs, was cleared of liability in a preterm formula case.
As a maker of condoms and baby formula, Reckitt Benckiser should be the perfect hedge. Instead, the UK consumer goods company has missed guidance on sales in 13 of the past 14 quarters.